BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30267476)

  • 1. GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells.
    Zhang Z; Tan X; Luo J; Cui B; Lei S; Si Z; Shen L; Yao H
    Cancer Med; 2018 Nov; 7(11):5611-5620. PubMed ID: 30267476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gα-13 induces C
    Lim WK; Chai X; Ghosh S; Ray D; Wang M; Rasheed SAK; Casey PJ
    J Biol Chem; 2019 Nov; 294(48):18192-18206. PubMed ID: 31636124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lncRNA TRG-AS1 promotes the growth of colorectal cancer cells through the regulation of P2RY10/GNA13.
    Shi L; Luo B; Deng L; Zhang Q; Li Y; Sun D; Zhang H; Zhuang L
    Scand J Gastroenterol; 2024 Jun; 59(6):710-721. PubMed ID: 38357893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
    Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
    Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
    Liu S; He L; Wu J; Wu X; Xie L; Dai W; Chen L; Xie F; Liu Z
    Cell Mol Life Sci; 2021 Dec; 78(24):8261-8281. PubMed ID: 34773477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer.
    Ma ZH; Shi PD; Wan BS
    Cytokine; 2021 Apr; 140():155433. PubMed ID: 33517196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERPINB5 promotes colorectal cancer invasion and migration by promoting EMT and angiogenesis via the TNF-α/NF-κB pathway.
    Liu BX; Xie Y; Zhang J; Zeng S; Li J; Tao Q; Yang J; Chen Y; Zeng C
    Int Immunopharmacol; 2024 Apr; 131():111759. PubMed ID: 38460302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.
    Tang J; Chen H; Wong CC; Liu D; Li T; Wang X; Ji J; Sung JJ; Fang JY; Yu J
    Oncogene; 2018 May; 37(22):3006-3021. PubMed ID: 29535419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer.
    Ou B; Zhao J; Guan S; Feng H; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Shen X; Zheng M; Lu A
    Oncotarget; 2016 Jul; 7(30):47637-47649. PubMed ID: 27356745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
    Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
    World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.
    Ruiz de Porras V; Bystrup S; Martínez-Cardús A; Pluvinet R; Sumoy L; Howells L; James MI; Iwuji C; Manzano JL; Layos L; Bugés C; Abad A; Martínez-Balibrea E
    Sci Rep; 2016 Apr; 6():24675. PubMed ID: 27091625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer.
    Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation.
    Gao Y; Nan X; Shi X; Mu X; Liu B; Zhu H; Yao B; Liu X; Yang T; Hu Y; Liu S
    BMC Cancer; 2019 Jul; 19(1):685. PubMed ID: 31299935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
    Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H
    Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorooctane sulfonate promotes the migration of colorectal cancer cells by inducing epithelial-mesenchymal transition.
    Li F; Chen L; Peng BX; Lei Y; Li M; Guo LH
    J Environ Sci (China); 2024 Nov; 145():1-12. PubMed ID: 38844310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
    Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of
    Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
    Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
    [No Abstract]   [Full Text] [Related]  

  • 19. GNA13 as a prognostic factor and mediator of gastric cancer progression.
    Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S
    Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
    Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
    Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.